Immediate Impact

53 standout
Sub-graph 1 of 25

Citing Papers

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
2 intermediate papers

Works of Elsa Curtit being referenced

Complete Histologic Response Induced by Sorafenib in Advanced Hepatocellular Carcinoma: A Case Report
2011
Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
2011

Author Peers

Author Last Decade Papers Cites
Elsa Curtit 207 111 101 45 423
Joanne Chiu 217 86 151 52 476
E. Day Werts 170 140 118 35 511
Johanna Wassermann 195 96 81 41 500
S Jelić 214 88 80 37 423
Manali Bhave 156 52 111 45 495
Hui-Ju Ch’ang 126 66 67 37 406
Yanmeng Li 136 148 137 42 471
Özge Gümüşay 211 79 145 46 399
C. L. Vogel 264 89 54 27 404
Hüseyin Engin 134 51 104 47 435

All Works

Loading papers...

Rankless by CCL
2026